Zobrazeno 1 - 10
of 10
pro vyhledávání: '"LUYIN DING"'
Autor:
Ming Lu, Panpan Zhang, Lin Shen, Kai Chen, Jianwei Yang, Lijie Song, Humphrey Gardner, Kedan Lin, Luyin Ding, Shuai Zhao, Yuan Geng, Jie Ding, Zailian Lu, Yedong Wang
Publikováno v:
Cancer Research. 83:CT263-CT263
Background: Porustobart (HBM4003) is a fully human heavy chain only monoclonal antibody targeting CTLA-4. In addition to blocking the CTLA-4 pathway, porustobart was engineered to deplete Treg cells by enhanced antibody-dependent cellular cytotoxicit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f0059bcf8fe05ce39d633fa2e58ca9d
https://doi.org/10.1158/1538-7445.am2023-ct263
https://doi.org/10.1158/1538-7445.am2023-ct263
Autor:
Shanzhi Gu, Paul L. de Souza, Yuankai Shi, Weiqing Han, SuXia Luo, Jing Chen, Daphne Day, Sophia Frentzas, John J. Park, Guoliang Shao, Shikai Wu, Meiyu Fang, Andrew Mark Haydon, Sanyuan Sun, Kaijian Lei, Luyin Ding, Rui Zuo, Xin Gan, Yuansheng Zhao, Xiaoxiang Chen
Publikováno v:
Journal of Clinical Oncology. 40:2641-2641
2641 Background: HBM4003 is a fully human heavy chain only monoclonal antibody (HCAb) to CTLA-4, which has been engineered to deplete Treg cells by enhanced antibody-dependent cellular cytotoxicity (ADCC) activity. In the Phase 1 dose escalation part
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::43ab476b813ef27e220e982c11860dbb
https://doi.org/10.1200/jco.2022.40.16_suppl.2641
https://doi.org/10.1200/jco.2022.40.16_suppl.2641
Autor:
Bixia Tang, Zhihong Chi, Rong Duan, Lu Si, Chuanliang Cui, Xinan Sheng, Xieqiao Yan, Lili Mao, Bin Lian, Xuan Wang, Siming Li, Li Zhou, Xue Bai, Xiaoting Wei, Luyin Ding, Xuan Chen, Xiaoxiang Chen, Jun Guo
Publikováno v:
Journal of Clinical Oncology. 40:e14586-e14586
e14586 Background: Combination therapy of ipilimumab plus PD-1 inhibitors has shown promising efficacy in various tumor types, demonstrating higher rates of response than either agent alone. HBM4003 is a fully human heavy chain only monoclonal antibo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cdfd99dec47bc74c3c12d6efe80dad7c
https://doi.org/10.1200/jco.2022.40.16_suppl.e14586
https://doi.org/10.1200/jco.2022.40.16_suppl.e14586
Publikováno v:
Oncology Letters. Mar2017, Vol. 13 Issue 3, p1315-1318. 4p.
Publikováno v:
Acta Haematologica. 137:117-122
Multiple nonleukemic myeloid sarcoma (MS) is a rare form of MS that is developed in multiple anatomic sites other than bone marrow at diagnosis, without a preceding myeloid neoplasm. The prevalence, prognosis, and optimal management of multiple nonle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a53e3b83aa02dc092c0b9ef1617031e9
https://doi.org/10.1159/000455998
https://doi.org/10.1159/000455998
Publikováno v:
Oncology Letters. Dec2015, Vol. 10 Issue 6, p3789-3792. 4p.
Publikováno v:
Oncology Letters. 2015, Vol. 9 Issue 1, p231-234. 4p.
Myeloid sarcoma is a type of malignant neoplasm composed of myeloblasts that locates extramedullary. The present study reports the case of a 31-year-old female who presented with upper abdominal pain, melena, vomiting and jaundice. The abdominal comp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ce5bf65e183f82081e5a93089a96835
https://europepmc.org/articles/PMC4888104/
https://europepmc.org/articles/PMC4888104/
Publikováno v:
Oncology letters. 13(3)
Adult sporadic Burkitt lymphoma (BL) is a rare aggressive neoplasm and represents ~1-5% of all lymphomas diagnosed in adults. The disease exhibits an aggressive clinical manifestation, which frequently involves the central nervous system (CNS) in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1dc6d9d7ea0546ed55a7d1642b8fb025
https://pubmed.ncbi.nlm.nih.gov/28454254
https://pubmed.ncbi.nlm.nih.gov/28454254
Myeloid sarcoma derived from the gastrointestinal tract: A case report and review of the literature.
Publikováno v:
Oncology Letters; Jun2016, Vol. 11 Issue 6, p4155-4159, 5p